Acute respiratory distress syndrome (ARDS) continues to be a tough nut to crack in critical care, taking lives despite years of research and better ventilator strategies. It is defined by acute ...

The following is a summary of "Heme-induced lung injury in human precision-cut lung slices: a new model for acute lung injury ...

VQ Biomedical, a startup born at Duke University, has secured $5 million in funding to advance a device it says will treat ...

In mechanically ventilated patients with ARDS, the treatment effect of neuromuscular blockade on mortality likely varies with respiratory elastance.

Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Inhaled sevoflurane significantly reduced ventilator-free ...

VQ Biomedical, spun out of Duke University, has developed a novel, minimally invasive catheter designed to deliver oxygen directly to the bloodstream. The catheter bypasses the lungs, giving ARDS ...

Inhaled sedation with sevoflurane in patients with moderate to severe acute respiratory distress syndrome (ARDS) resulted in fewer ventilator-free days at 28 days and lower 90-day survival than ...

For patients with moderate to severe acute respiratory distress syndrome (ARDS), prolonged sedation with the inhaled volatile ...